These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 20953662)
1. Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. Ewelt C; Goeppert M; Rapp M; Steiger HJ; Stummer W; Sabel M J Neurooncol; 2011 Jul; 103(3):611-8. PubMed ID: 20953662 [TBL] [Abstract][Full Text] [Related]
2. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients. Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331 [TBL] [Abstract][Full Text] [Related]
3. The impact of sequential vs. combined radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on survival of patients with primary glioblastoma--a single centre retrospective study. Rapp M; Goeppert M; Felsberg J; Steiger HJ; Sabel M Br J Neurosurg; 2013 Aug; 27(4):430-5. PubMed ID: 23418781 [TBL] [Abstract][Full Text] [Related]
4. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era. Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327 [TBL] [Abstract][Full Text] [Related]
5. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499 [TBL] [Abstract][Full Text] [Related]
6. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121 [TBL] [Abstract][Full Text] [Related]
7. Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma. Minniti G; De Sanctis V; Muni R; Rasio D; Lanzetta G; Bozzao A; Osti MF; Salvati M; Valeriani M; Cantore GP; Maurizi Enrici R J Neurooncol; 2009 Jan; 91(1):95-100. PubMed ID: 18758912 [TBL] [Abstract][Full Text] [Related]
8. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients. Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors. Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394 [TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Jeon HJ; Kong DS; Park KB; Lee JI; Park K; Kim JH; Kim ST; Lim DH; Kim WS; Nam DH Clin Neurol Neurosurg; 2009 Oct; 111(8):679-82. PubMed ID: 19640635 [TBL] [Abstract][Full Text] [Related]
11. Survival benefits of hypofractionated radiotherapy combined with temozolomide or temozolomide plus bevacizumab in elderly patients with glioblastoma aged ≥ 75 years. Ohno M; Miyakita Y; Takahashi M; Igaki H; Matsushita Y; Ichimura K; Narita Y Radiat Oncol; 2019 Nov; 14(1):200. PubMed ID: 31718669 [TBL] [Abstract][Full Text] [Related]
12. Prognosis of patients with multifocal glioblastoma: a case-control study. Patil CG; Yi A; Elramsisy A; Hu J; Mukherjee D; Irvin DK; Yu JS; Bannykh SI; Black KL; Nuño M J Neurosurg; 2012 Oct; 117(4):705-11. PubMed ID: 22920963 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide. Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Ciner F; Mertsoylu H; Tufan K J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530 [TBL] [Abstract][Full Text] [Related]
15. Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis. Hoffermann M; Bruckmann L; Kariem Mahdy A; Asslaber M; Payer F; von Campe G Clin Neurol Neurosurg; 2015 Jan; 128():60-9. PubMed ID: 25462098 [TBL] [Abstract][Full Text] [Related]
16. Glioblastoma in the elderly: the Memorial Sloan-Kettering Cancer Center Experience (1997-2007). Iwamoto FM; Cooper AR; Reiner AS; Nayak L; Abrey LE Cancer; 2009 Aug; 115(16):3758-66. PubMed ID: 19484785 [TBL] [Abstract][Full Text] [Related]
17. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution. Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219 [TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Gerstein J; Franz K; Steinbach JP; Seifert V; Fraunholz I; Weiss C; Rödel C Radiother Oncol; 2010 Dec; 97(3):382-6. PubMed ID: 20850883 [TBL] [Abstract][Full Text] [Related]
19. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre. Gauden AJ; Hunn A; Erasmus A; Waites P; Dubey A; Gauden SJ J Clin Neurosci; 2009 Sep; 16(9):1174-9. PubMed ID: 19540125 [TBL] [Abstract][Full Text] [Related]
20. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea. Kim BS; Seol HJ; Nam DH; Park CK; Kim IH; Kim TM; Kim JH; Cho YH; Yoon SM; Chang JH; Kang SG; Kim EH; Suh CO; Jung TY; Lee KH; Kim CY; Kim IA; Hong CK; Yoo H; Kim JH; Kang SH; Kang MK; Kim EY; Kim SH; Chung DS; Hwang SC; Song JH; Cho SJ; Lee SI; Lee YS; Ahn KJ; Kim SH; Lim DH; Gwak HS; Lee SH; Hong YK Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]